Risk of Candida Infection and Serious Infections in Patients with Moderate-to-Severe Psoriasis Receiving Biologics: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Biological agents used to treat moderate-to-severe plaque psoriasis have been associated with Candida infection and other serious infections. It is, however, necessary to verify whether biologic agents increase the risk of Candida infection and serious infections and whether these risks...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yue, Zhou, Baosen, Wang, Zhen, Xu, Guijuan, Wang, Lili, Zhang, Tingting, Zhang, Yanping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519312/
https://www.ncbi.nlm.nih.gov/pubmed/36212052
http://dx.doi.org/10.1155/2022/2442603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519312/
https://www.ncbi.nlm.nih.gov/pubmed/36212052
http://dx.doi.org/10.1155/2022/2442603

Ejemplares similares